Skip to content

Scholar Rock SRRK Operating Income

Operating Income at other companies

Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
-$54.12M-17.7%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$44.96M-95.4%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
-$125.28M-2.4%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$73.23M+15.6%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$103.61M-38.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$105.96M-1.5%

Other financials

Income statement

See full
Revenue-
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's operating income?
Scholar Rock (SRRK) reported operating income of -$102.02M in Q1 2026.
How has Scholar Rock's operating income changed year-over-year?
Scholar Rock's operating income decreased by 32.3% year-over-year, from -$77.09M to -$102.02M.
What is the long-term trend for Scholar Rock's operating income?
Over 4 years (2021 to 2025), Scholar Rock's operating income has grown at a 31.2% compound annual growth rate (CAGR), from -$129.92M to -$384.65M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.